| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $925.4M | +7.5% |
| Cost of Revenue | $486.8M | +5.6% |
| Gross Profit | $438.6M | +9.7% |
| R&D Expense | $38.9M | +11.1% |
| SG&A Expense | $348.2M | +2.1% |
| Operating Income | $51.5M | +107.7% |
| Pre-tax Income | $32.7M | +196.5% |
| Income Tax | $2.9M | +7.4% |
| Net Income | $28.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $412.3M | +135.3% |
| Accounts Receivable | $181.6M | +2.2% |
| Inventory | $152.6M | +14.6% |
| Current Assets | $893.7M | +50.3% |
| Total Assets | $3.59B | +36.1% |
| Current Liabilities | $316.1M | +20.0% |
| Long-term Debt | $443.1M | -35.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $143.3M | +44.6% |
| Capital Expenditures | $36.4M | -25.4% |
| Investing Cash Flow | -$694.6M | -1489.5% |
| Financing Cash Flow | $775.9M | — |
| Free Cash Flow | $106.9M | +112.5% |
| +179.8% |
| EPS (Basic) | $0.13 | +172.2% |
| EPS (Diluted) | $0.11 | +161.1% |
| Total Liabilities |
| $1.67B |
| +55.2% |
| Stockholders' Equity | $1.87B | +24.0% |